The HATS study, conducted by Brown and colleagues, showed that simvastatin–niacin combination therapy provided a large reduction in cardiovascular risk compared with placebo. [4] The small population ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback